Overall, considering all health centers for the first aim, mean hepatitis B vaccination timeliness improved in the intervention group post intervention to a greater degree than in the control group, as depicted by the positive post-level difference between intervention and control health facilities. This evidence concerns the gene PPIB and hepatitis A virus infection.